BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15661228)

  • 1. Lymph node metastases in low-grade endometrial stromal sarcoma.
    Riopel J; Plante M; Renaud MC; Roy M; TĂȘtu B
    Gynecol Oncol; 2005 Feb; 96(2):402-6. PubMed ID: 15661228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.
    Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Malone JM; Morris RT
    Obstet Gynecol; 2008 Nov; 112(5):1102-8. PubMed ID: 18978112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade endometrial stromal sarcoma with retroperitoneal metastases: an unusual case report.
    Guzelmeric K; Ergen B; Pirimoglu ZM; Gecer MO; Unal O; Turan C
    Arch Gynecol Obstet; 2008 Feb; 277(2):179-82. PubMed ID: 17823808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma.
    Dos Santos LA; Garg K; Diaz JP; Soslow RA; Hensley ML; Alektiar KM; Barakat RR; Leitao MM
    Gynecol Oncol; 2011 May; 121(2):319-22. PubMed ID: 21276609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern tendencies in the surgical treatment of the early detected endometrial cancers--with or without lymph node dissection].
    Akush Ginekol (Sofiia); 2008; 47(6):22-5. PubMed ID: 19230261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
    Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
    Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
    Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endolymphatic stromal myosis associated with tamoxifen use.
    Eddy GL; Mazur MT
    Gynecol Oncol; 1997 Feb; 64(2):262-4. PubMed ID: 9038273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
    Abu-Rustum NR; Gomez JD; Alektiar KM; Soslow RA; Hensley ML; Leitao MM; Gardner GJ; Sonoda Y; Chi DS; Barakat RR
    Gynecol Oncol; 2009 Nov; 115(2):236-8. PubMed ID: 19666190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial stromal sarcoma resembling adenomyosis and menstrual-phase endometrium.
    Brunisholz Y; Miller J; Scurry J; Proietto A
    Gynecol Oncol; 2004 Oct; 95(1):256-9. PubMed ID: 15385142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade endometrial stromal sarcoma with florid intravenous component.
    Lo KW; Yu MY; Cheung TH
    Gynecol Obstet Invest; 2008; 66(1):8-11. PubMed ID: 18216492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the sentinel node procedure to stage endometrial cancer.
    Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
    Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
    Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
    Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
    Abu-Rustum NR; Chi DS; Leitao M; Oke EA; Hensley ML; Alektiar KM; Barakat RR
    Gynecol Oncol; 2008 Oct; 111(1):46-8. PubMed ID: 18657853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade endometrial stromal sarcoma recurring with multiple bone and lung metastases: report of a case.
    Matsuura Y; Yasunaga K; Kuroki H; Inagaki H; Kashimura M
    Gynecol Oncol; 2004 Mar; 92(3):995-8. PubMed ID: 14984975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade endometrial stromal sarcoma with cardiovascular involvement--a report of three cases.
    Tabata T; Takeshima N; Hirai Y; Hasumi K
    Gynecol Oncol; 1999 Dec; 75(3):495-8. PubMed ID: 10600315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma.
    Lim MC; Lee S; Seo SS
    Onkologie; 2010; 33(5):260-2. PubMed ID: 20502061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.